Skip to main content
Top
Published in: Clinical Rheumatology 12/2015

01-12-2015 | Original Article

Bone mineral density reduction in adolescents with systemic erythematosus lupus: association with lack of vitamin D supplementation

Authors: M. Caetano, M. T. Terreri, T. Ortiz, M. Pinheiro, F. Souza, R. Sarni

Published in: Clinical Rheumatology | Issue 12/2015

Login to get access

Abstract

The aim of this study is to evaluate body composition and the bone mineral density in female adolescents with juvenile systemic lupus erythematosus. Body composition (BC) and bone mineral density (BMD) were evaluated in an observational cohort study with 35 postmenarcheal adolescent females. The variables studied were as follows: current and cumulative corticosteroid dose, intake of supplements containing calcium and vitamin D, 24-h proteinuria, body mass index (BMI), and height for age (Z-score). BC was assessed using dual-energy X-ray absorptiometry (DXA) at two time points (median interval of 1.2 years). The fat mass index (FMI = fat mass in kilograms divided by the height in meters squared) and lean mass index (LMI = lean mass in kilograms divided by the height in meters squared) were calculated based on the DXA results. BMD was classified according to the International Society of Clinical Densitometry (low BMD for chronological age < −2.0 standard deviations). .The mean age of the subjects was 15.4 ± 1.8 years. Of patients, 54.3 % were normal weight, 22.8 % were overweight, 22.8 % were obese, and 8.6 % had short stature. Low BMD for chronological age was observed in 42.8 % of patients, and 60 % were not taking vitamin D. There was no significant difference between the two time points with respect to FMI, LMI, or body mass index Z-score (ZBMI); however, BMD has decreased significantly (p = 0.011). There was an association between not taking a vitamin D supplement and decreased BMD (p = 0.027). Almost half of the patients had altered nutritional status. The BMD decrease in adolescents with juvenile systemic lupus erythematosus (JSLE) was associated with the lack of vitamin D supplementation, highlighting the importance of well-defined vitamin D supplementation protocols.
Literature
1.
go back to reference Rood MJ, ten Cate R, van Suijlekom-Smit LW et al (1999) Childhood-onset Systemic Lupus Erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 28:222–226CrossRefPubMed Rood MJ, ten Cate R, van Suijlekom-Smit LW et al (1999) Childhood-onset Systemic Lupus Erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 28:222–226CrossRefPubMed
2.
go back to reference Hashkes PJ, Wright BM, Lauer MS et al (2010) Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum 62:599–608PubMed Hashkes PJ, Wright BM, Lauer MS et al (2010) Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum 62:599–608PubMed
4.
go back to reference Müller K, Kriegbaum NJ, Baslund B, Sørensen OH, Thymann M, Bentzen K (1995) Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 14:397–400CrossRefPubMed Müller K, Kriegbaum NJ, Baslund B, Sørensen OH, Thymann M, Bentzen K (1995) Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 14:397–400CrossRefPubMed
5.
go back to reference Lahita RG, Bradlow HL, Ginzler E, Pang S, New M (1987) Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 30:241–248CrossRefPubMed Lahita RG, Bradlow HL, Ginzler E, Pang S, New M (1987) Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 30:241–248CrossRefPubMed
6.
go back to reference Swaak AJ, van den Brink HG, Aarden LA (1996) Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol 25:233–238CrossRefPubMed Swaak AJ, van den Brink HG, Aarden LA (1996) Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol 25:233–238CrossRefPubMed
7.
go back to reference Tang XL, Qin L, Kwok AW et al (2013) Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT. Osteoporos Int 24:1817–1826CrossRefPubMed Tang XL, Qin L, Kwok AW et al (2013) Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT. Osteoporos Int 24:1817–1826CrossRefPubMed
8.
go back to reference Tang XL, Griffith JF, Qin L, Hung VW, Kwok AW et al (2013) SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength. Lupus 22.11:1162–1168 Tang XL, Griffith JF, Qin L, Hung VW, Kwok AW et al (2013) SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength. Lupus 22.11:1162–1168
9.
go back to reference Borba VZ, Matos PG, da Silva Viana PR, Fernandes A, Sato EI, Lazaretti-Castro M (2005) High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14:529–533CrossRefPubMed Borba VZ, Matos PG, da Silva Viana PR, Fernandes A, Sato EI, Lazaretti-Castro M (2005) High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14:529–533CrossRefPubMed
10.
go back to reference Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:2044–2050CrossRefPubMed Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:2044–2050CrossRefPubMed
11.
go back to reference Helba M, Binkovitz LA (2009) Pediatric body composition analysis with dual-energy X-ray absorptiometry. Pediatr Radiol 39:647–656CrossRefPubMed Helba M, Binkovitz LA (2009) Pediatric body composition analysis with dual-energy X-ray absorptiometry. Pediatr Radiol 39:647–656CrossRefPubMed
12.
go back to reference Castro TC, Terreri MT, Szejnfeld VL et al (2002) Bone mineral density in juvenile systemic lupus erythematosus. Braz J Med Biol Res 35:1159–1163PubMed Castro TC, Terreri MT, Szejnfeld VL et al (2002) Bone mineral density in juvenile systemic lupus erythematosus. Braz J Med Biol Res 35:1159–1163PubMed
13.
go back to reference Alsufyani KA, Ortiz-Alvarez O, Cabral DA et al (2005) Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise. J Rheumatol 32:729–733PubMed Alsufyani KA, Ortiz-Alvarez O, Cabral DA et al (2005) Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise. J Rheumatol 32:729–733PubMed
14.
go back to reference Lilleby V, Lien G, Frey Frøslie K, Haugen M, Flatø B, Førre Ø (2005) Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum 52:2051–2059CrossRefPubMed Lilleby V, Lien G, Frey Frøslie K, Haugen M, Flatø B, Førre Ø (2005) Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum 52:2051–2059CrossRefPubMed
15.
go back to reference Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E et al (2007) Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum 56:1966–1973CrossRefPubMed Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E et al (2007) Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum 56:1966–1973CrossRefPubMed
16.
go back to reference Regio P, Bonfá E, Takayama L, Pereira R (2008) The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus. Lupus 17:787–792CrossRefPubMed Regio P, Bonfá E, Takayama L, Pereira R (2008) The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus. Lupus 17:787–792CrossRefPubMed
17.
go back to reference Casella CB, Seguro LP, Takayama L, Medeiros D, Bonfa E, Pereira RM (2012) Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 21:1335–1342CrossRefPubMed Casella CB, Seguro LP, Takayama L, Medeiros D, Bonfa E, Pereira RM (2012) Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 21:1335–1342CrossRefPubMed
18.
go back to reference Trapani S, Civinini R, Ermini M, Paci E, Falcini F (1998) Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 18:45–49CrossRefPubMed Trapani S, Civinini R, Ermini M, Paci E, Falcini F (1998) Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 18:45–49CrossRefPubMed
19.
go back to reference Lim LS, Benseler SM, Tyrrell PN et al (2012) Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients. Ann Rheum Dis 71:1686–1691CrossRefPubMed Lim LS, Benseler SM, Tyrrell PN et al (2012) Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients. Ann Rheum Dis 71:1686–1691CrossRefPubMed
20.
go back to reference Abdwani R, Abdulla E, Yaroubi S, Bererhi H, Al-Zakwani I (2015) Bone mineral density in juvenile onset systemic lupus erythematosus. Indian Pediatr 52:38–40CrossRefPubMed Abdwani R, Abdulla E, Yaroubi S, Bererhi H, Al-Zakwani I (2015) Bone mineral density in juvenile onset systemic lupus erythematosus. Indian Pediatr 52:38–40CrossRefPubMed
21.
go back to reference Mok CC (2013) Vitamin D, and systemic lupus erythematosus: an update. Expert Rev Clin Immunol 9:453–463CrossRefPubMed Mok CC (2013) Vitamin D, and systemic lupus erythematosus: an update. Expert Rev Clin Immunol 9:453–463CrossRefPubMed
22.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed
23.
go back to reference de Onis M, Garza C, Victora CG (2003) The WHO Multicentre Growth Reference Study: strategy for developing a new international growth reference. Forum Nutr 56:238–240PubMed de Onis M, Garza C, Victora CG (2003) The WHO Multicentre Growth Reference Study: strategy for developing a new international growth reference. Forum Nutr 56:238–240PubMed
24.
go back to reference Khan AA, Bachrach L, Brown JP et al (2004) Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children. J Clin Densitom 7:51–64CrossRefPubMed Khan AA, Bachrach L, Brown JP et al (2004) Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children. J Clin Densitom 7:51–64CrossRefPubMed
25.
go back to reference Lilleby V, Haugen M, Mørkrid L, Frey Frøslie K, Holven KB, Førre O (2007) Body composition, lipid and lipoprotein levels in childhood-onset systemic lupus erythematosus. Scand J Rheumatol 36:40–47CrossRefPubMed Lilleby V, Haugen M, Mørkrid L, Frey Frøslie K, Holven KB, Førre O (2007) Body composition, lipid and lipoprotein levels in childhood-onset systemic lupus erythematosus. Scand J Rheumatol 36:40–47CrossRefPubMed
26.
go back to reference Tekano JL, Tucker L, Khattra P (2006) Limiting obesity in children with rheumatic diseases requiring corticosteroid therapy [abstract]. Arthritis Rheum 54:S529 Tekano JL, Tucker L, Khattra P (2006) Limiting obesity in children with rheumatic diseases requiring corticosteroid therapy [abstract]. Arthritis Rheum 54:S529
27.
go back to reference Abou-Raya A, Abou-Raya S, Helmii M (2013) The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 40:265–272CrossRefPubMed Abou-Raya A, Abou-Raya S, Helmii M (2013) The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 40:265–272CrossRefPubMed
28.
go back to reference Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A (2011) Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 20:1155–1160CrossRefPubMed Bonakdar ZS, Jahanshahifar L, Jahanshahifar F, Gholamrezaei A (2011) Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 20:1155–1160CrossRefPubMed
29.
go back to reference Hamza RT, Awwad KS, Ali MK, Hamed AI (2011) Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit 17:CR711–CR718PubMedCentralCrossRefPubMed Hamza RT, Awwad KS, Ali MK, Hamed AI (2011) Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit 17:CR711–CR718PubMedCentralCrossRefPubMed
30.
go back to reference Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117CrossRefPubMed Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117CrossRefPubMed
31.
go back to reference Sumethkul K, Boonyaratavej S, Kitumnuaypong T et al (2013) The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int 33:1461–1467CrossRefPubMed Sumethkul K, Boonyaratavej S, Kitumnuaypong T et al (2013) The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol Int 33:1461–1467CrossRefPubMed
32.
go back to reference Toloza SM, Cole DE, Gladman DD, Ibañez D, Urowitz MB (2010) Vitamin D insufficiency in a large female SLE cohort. Lupus 19:13–19CrossRefPubMed Toloza SM, Cole DE, Gladman DD, Ibañez D, Urowitz MB (2010) Vitamin D insufficiency in a large female SLE cohort. Lupus 19:13–19CrossRefPubMed
33.
go back to reference Souto M, Coelho A, Guo C et al (2011) Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus 20:1019–1026CrossRefPubMed Souto M, Coelho A, Guo C et al (2011) Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus 20:1019–1026CrossRefPubMed
34.
go back to reference Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001; 44:1496–503 Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001; 44:1496–503
Metadata
Title
Bone mineral density reduction in adolescents with systemic erythematosus lupus: association with lack of vitamin D supplementation
Authors
M. Caetano
M. T. Terreri
T. Ortiz
M. Pinheiro
F. Souza
R. Sarni
Publication date
01-12-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3011-1

Other articles of this Issue 12/2015

Clinical Rheumatology 12/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.